✦ LIBER ✦

Phase I/II trial of capecitabine and oxaliplatin in combination with bevacizumab and imatinib in patients with metastatic colorectal cancer: AIO KRK 0205

✍ Scribed by Hoehler, T; von Wichert, G; Schimanski, C; Kanzler, S; Moehler, M H; Hinke, A; Seufferlein, T; Siebler, J; Hochhaus, A; Arnold, D; Hallek, M; Hofheinz, R; Hacker, U T

Book ID: 120879181
Publisher: Nature Publishing Group
Year: 2013
Tongue: English
Weight: 202 KB
Volume: 109
Category: Article
ISSN: 0007-0920
DOI: 10.1038/bjc.2013.409

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Capecitabine and bevacizumab for non-res

Capecitabine and bevacizumab for non-resectable metastatic colorectal cancer patients: final results from phase II AIO KRK 0105 trial

✍ Stein, Alexander; Kretzschmar, Albrecht; Behringer, Dirk; Wolff, Thomas; Zimber, 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 198 KB

667 PUBLICATION Capecitabine and oxalipl

667 PUBLICATION Capecitabine and oxaliplatin (XELOX) in combination with bevacizumab in the treatment of metastatic colorectal cancer: results of a phase II trial

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 126 KB

A phase I trial of vandetanib combined w

A phase I trial of vandetanib combined with capecitabine, oxaliplatin and bevacizumab for the first-line treatment of metastatic colorectal cancer

✍ Elwyn C. Cabebe, George A. Fisher, Branimir I. Sikic 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 112 KB

Cetuximab Plus Capecitabine and Irinotec

Cetuximab Plus Capecitabine and Irinotecan Compared With Cetuximab Plus Capecitabine and Oxaliplatin As First-Line Treatment for Patients With Metastatic Colorectal Cancer: AIO KRK-0104--A Randomized Trial of the German AIO CRC Study Group

✍ Moosmann, N.; von Weikersthal, L. F.; Vehling-Kaiser, U.; Stauch, M.; Hass, H. G 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 169 KB

A phase I trial of imatinib in combinati

A phase I trial of imatinib in combination with mFOLFOX6–bevacizumab in patients with advanced colorectal cancer

✍ M. Michael, J. Zalcberg, P. Gibbs, L. Lipton… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 251 KB

Phase I study of dasatinib in combinatio

Phase I study of dasatinib in combination with capecitabine, oxaliplatin and bevacizumab followed by an expanded cohort in previously untreated metastatic colorectal cancer

✍ Strickler, John H.; McCall, Shannon; Nixon, Andrew B.; Brady, John C.; Pang, Her 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 461 KB